Shelley Shaw
Head of Oncology Marketing Astellas Pharma
Seminars
Wednesday 20th May 2026
Successfully Co-Launching a Novel CDx & Oncology Treatment to Enable Patient Access to Life-Changing Therapies
2:30 pm
- Best practice examples of launching novel CDx and oncology therapies to ensure streamlined market access
- Considering the challenges and priorities of simultaneously commercialising CDx and precision therapies
Tuesday 19th May 2026
Strategically Executing Biomarker-Driven Clinical Trials within Japan to Facilitate CDx Development Chaired by –
Tuesday 19th May 2026
Panel Discussion: Choosing the Right CDx Partner – Lessons from Japan & Beyond
9:30 am
- Key factors determining the success of a CDx partnership
- Challenges and lessons from CDx development in Japan and globally
- What pharma look for in a CDx partner, and what CDx partners want pharma to know
